Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth

Epidemiology

Volumn 23, Issue 5, 2012, Pages 677-685

  Yonkers, Kimberly A ^a,b,c   Norwitz, Errol R ^d   Smith, Megan V ^a,e   Lockwood, Charles J ^f   Gotman, Nathan ^a   Luchansky, Edward ^g   Lin, Haiqun ^c   Belanger, Kathleen ^c  

^a Departments of Psychiatry   (United States)

^b Depertment of Obstetrics Gynecology   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g BRIDGEPORT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREGNANCY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 84864877681     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31825838e9     Document Type: Article

References (42)

1. Chambers C, Johnson K, Dick L, Felix R, Jones K. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335:1010-1015.
2. Davis RL, Rubanowice D, McPhillips H, et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf. 2007;16:1086-1094.
3. Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med. 2004;158:312-316.
4. Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med. 2009;163:949-954.
5. Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40:1723-1733.
6. Simon G, Cunningham M, Davis R. Outcomes of prenatal antidepressant exposure. Am J Psychiatry. 2002;159:2055-2061.
7. Toh SS, Mitchell AA, Louik CS, Werler MM, Chambers CD, Hernandez-Diaz SM. Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction. J Clin Psychopharmacol. 2009;29:555-560.
8. Wen SW, Yang Q, Garner P, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006;194: 961.
9. Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166:557-566.
10. Colvin L, Slack-Smith L, Stanley FJ, Bower C. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A Clin Mol Teratol. 2011;91: 142-152.
11. Kulin NA, Pastuszak A, Sage SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors. JAMA. 1998;279:609-610.
12. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol. 2005;106: 1289-1296.
13. Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA. 1993; 269:2246-2248.
14. Dayan J, Creveuil C, Marks MN, et al. Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort study among women with early and regular care. Psychosom Med. 2006;68: 938-946.
15. Hedegaard M, Henriksen TB, Sabroe S, Secher NJ. Psychological distress in pregnancy and preterm delivery. Br Med J. 1993;307:234-239.
16. Jesse DE, Seaver W, Wallace DC. Maternal psychosocial risks predict preterm birth in a group of women from Appalachia. Midwifery. 2003; 19:191-202.
17. Neggers Y, Goldenberg R, Cliver S, Hauth J. Effects of domestic violence on preterm birth and low birth weight. Acta Obstet Gynecol Scand. 2004;83:455-460.
18. Orr S, James S, Prince CB. Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, MD. Am J Epidemiol. 2002;156:797-802.
19. Rondo P, Ferreira R, Nogueira F, Ribeiro M, Lobert H, Artes R. Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardation. Eur J Clin Nutr. 2003;57:266-272.
20. Andersson L, Sundstrom-Poromaa I, Wulff M, Astrom M, Bixo M. Neonatal outcome following maternal antenatal depression and anxiety: a population-based study. Am J Epidemiol. 2004;159:872-881.
21. Copper R, Goldenberg RL, Das A, et al. The preterm prediction study: maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation. Am J Obstet Gynecol. 1996;175:1286-1292.
22. Diego MA, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, Gonzalez-Quintero VH. Prenatal depression restricts fetal growth. Early Hum Dev. 2009;85:65-70.
23. Dole N, Savitz D, Hertz-Picciotto I, Siega-Riz A, McMahon M, Buekens P. Maternal stress and preterm birth. Am J Epidemiol. 2003;157:14-24.
24. Gavin AR, Holzman C, Siefert K, Tian Y. Maternal depressive symptoms, depression, and psychiatric medication use in relation to risk of preterm delivery. Womens Health Issues. 2009;19:325-334.
25. Haas JS, Fuentes-Afflick E, Stewart AL, et al. Prepregnancy health status and the risk of preterm delivery. Arch Pediatr Adolesc Med. 2005;159:58-63.
26. Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study. Hum Reprod. 2009;24:146-153.
27. Perkin M, Bland J, Peacock J, Anderson H. The effect of anxiety and depression during pregnancy on obstetric complications. Br J Obstet Gynaecol. 1993;100:629-634.
28. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry. 2007;164:1206-1213.
29. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin re-uptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63:898-906.
30. Yonkers KA, Gotman N, Smith MV, et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology. 2011;22:848-854.
31. Wittchen H-U. Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994;28:57-84.
32. Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51: 8-19.
33. Kessler R, Nelson C, McGonagle K, Liu J, Swartz M, Blazer D. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry. 1996;168:17-30.
34. Kessler RC, Avenevoli S, Costello EJ, et al. National Comorbidity Survey Replication Adolescent supplement (NCS-A): II. Overview and design. J Am Acad Child Adolesc Psychiatry. 2009;48:380-385.
35. Falsetti S, Resnick H, Pesick P, Kilpatrick D. The modified PTSD symptom scale: a brief self-report measure of posttraumatic stress disorder. Behav Ther. 1993;16:161-162.
36. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67:1012-1024.
37. Einarson A, Choi J, Einarson TR, Koren G. Adverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth. Depress Anxiety. 2010;27:35-38.
38. Calderon-Margalit R, Qiu C, Ornoy A, Siscovick DS, Williams MA. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol. 2009;201:579.e1-579.e8.
39. Nordeng H, VanGelder MM, Spiqset O, Koren G, Einarsen A, Eberhard-Gran M. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian mother and child cohort study. J Clin Psychopharmacology. 2012;32:186-194.
40. Warner-Schmidt JL, Vanover KE, Chen EY, Marshall JJ, Greengard P. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci USA. 2011;108:9262-9267.
41. Norwitz E, Lye S. Biology of parturition.In: Creasy R, Resnick R, Iams J, Lockwood C, Moore T, eds. Creasy & Resnick's Maternal-Fetal Medicine. 6th ed. Philadelphia: Elsevier, Inc; 2009:69-85.
42. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry. 2008;192:338-343.